BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7615542)

  • 1. Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor.
    Higazi A; Cohen RL; Henkin J; Kniss D; Schwartz BS; Cines DB
    J Biol Chem; 1995 Jul; 270(29):17375-80. PubMed ID: 7615542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1.
    Higazi AA; Mazar A; Wang J; Reilly R; Henkin J; Kniss D; Cines D
    Blood; 1996 May; 87(9):3545-9. PubMed ID: 8611676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of plasma clots by urokinase-soluble urokinase receptor complexes.
    Higazi AA; Bdeir K; Hiss E; Arad S; Kuo A; Barghouti I; Cines DB
    Blood; 1998 Sep; 92(6):2075-83. PubMed ID: 9731065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the single-chain urokinase-urokinase receptor complex activity by plasminogen and fibrin: novel mechanism of fibrin specificity.
    Higazi AA; Ajawi F; Akkawi S; Hess E; Kuo A; Cines DB
    Blood; 2005 Feb; 105(3):1021-8. PubMed ID: 15353482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins.
    Higazi AA; Upson RH; Cohen RL; Manuppello J; Bognacki J; Henkin J; McCrae KR; Kounnas MZ; Strickland DK; Preissner KT; Lawler J; Cines DB
    Blood; 1996 Jul; 88(2):542-51. PubMed ID: 8695802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble human urokinase receptor is composed of two active units.
    Higazi AA; Mazar A; Wang J; Quan N; Griffin R; Reilly R; Henkin J; Cines DB
    J Biol Chem; 1997 Feb; 272(8):5348-53. PubMed ID: 9030610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of single chain urokinase binding, internalization, and degradation by a plasminogen activator inhibitor 1-derived peptide.
    Zhang L; Strickland DK; Cines DB; Higazi AA
    J Biol Chem; 1997 Oct; 272(43):27053-7. PubMed ID: 9341144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of single chain urokinase by small peptides.
    Higazi A al-R ; Cines D
    Thromb Res; 1996 Nov; 84(4):243-52. PubMed ID: 8948049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile.
    Murciano JC; Higazi AA; Cines DB; Muzykantov VR
    J Control Release; 2009 Nov; 139(3):190-6. PubMed ID: 19616049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A region in domain II of the urokinase receptor required for urokinase binding.
    Bdeir K; Kuo A; Mazar A; Sachais BS; Xiao W; Gawlak S; Harris S; Higazi AA; Cines DB
    J Biol Chem; 2000 Sep; 275(37):28532-8. PubMed ID: 10864923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kringle stabilizes urokinase binding to the urokinase receptor.
    Bdeir K; Kuo A; Sachais BS; Rux AH; Bdeir Y; Mazar A; Higazi AA; Cines DB
    Blood; 2003 Nov; 102(10):3600-8. PubMed ID: 12881310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase.
    Chang AW; Kuo A; Barnathan ES; Okada SS
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1855-60. PubMed ID: 9848876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel interactions between urokinase and its receptor.
    Shliom O; Huang M; Sachais B; Kuo A; Weisel JW; Nagaswami C; Nassar T; Bdeir K; Hiss E; Gawlak S; Harris S; Mazar A; Higazi AA
    J Biol Chem; 2000 Aug; 275(32):24304-12. PubMed ID: 10801829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.
    Larusch GA; Merkulova A; Mahdi F; Shariat-Madar Z; Sitrin RG; Cines DB; Schmaier AH
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H305-20. PubMed ID: 23709605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism.
    Schwartz BS
    J Biol Chem; 1994 Mar; 269(11):8319-23. PubMed ID: 7907591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits.
    Komissarov AA; Mazar AP; Koenig K; Kurdowska AK; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L568-77. PubMed ID: 19666776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unesterified long chain fatty acids inhibit the binding of single chain urokinase to the urokinase receptor.
    al-Roof Higazi A; Aceto JF; Kniss D; Upson R; Cohen R; Dichek DA; Cines DB
    Biochemistry; 1996 May; 35(21):6884-90. PubMed ID: 8639640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sequence-dependent monoclonal antibody specific for single-chain urokinase.
    Charpie JR; Haber E; Matsueda GR
    Biochem Biophys Res Commun; 1988 Apr; 152(2):910-5. PubMed ID: 3365258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR; De Cock F; Collen D
    Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator.
    Frenette G; Tremblay RR; Lazure C; Dube JY
    Int J Cancer; 1997 May; 71(5):897-9. PubMed ID: 9180162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.